Entrada Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
TRDA on Nasdaq
Industry
Pharmaceutical Preparations
Location
One Design Center Place, Suite 17 500, Boston, Massachusetts

Insiders trading volume in the past year

Entrada Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MPM BioVentures 2014, L.P. 10%+ Owner $70.8 M Nov 2, 2021
Mpm Bioventures 2018, L.P. 10%+ Owner $70.8 M Nov 2, 2021
Baker Bros. Advisors Lp 10%+ Owner $45.8 M +$50 M Jun 25, 2024
Roche Holding Ltd 10%+ Owner $45 M Nov 2, 2021
Redmile Group, LLC 10%+ Owner $31.3 M Nov 2, 2021
5AM Ventures V, L.P. 10%+ Owner $18.1 M Nov 2, 2021
Dipal Doshi CEO, Director $5.44 M -$169 K -3.02% Jun 13, 2024
Natarajan Sethuraman Chief Scientific Officer $2.89 M -$610 K -17.4% May 16, 2024
Nathan J. Dowden President & COO $1.69 M -$164 K -8.82% Mar 6, 2024
Peter S. Kim Director $1.58 M +$642 K +68.1% Jun 13, 2024
Nerissa Kreher Chief Medical Officer $640 K -$406 K -38.8% Sep 1, 2023
Kory James Wentworth Chief Financial Officer $175 K -$438 K -71.5% Mar 15, 2024
Bernhardt G. Zeiher Director Jun 13, 2024
Kush Parmar Director, 10%+ Owner Jun 13, 2024
Gina Chapman Director Jun 13, 2024
Todd Foley Director, 10%+ Owner Jun 2, 2022
John F. Crowley Director Jun 8, 2023
Mary Thistle Director Jun 13, 2024
Carole Nuechterlein Director Jun 2, 2022

Recent Insider Transactions by Companies or Individuals for Entrada Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership